[go: up one dir, main page]

NO308644B1 - Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat - Google Patents

Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat

Info

Publication number
NO308644B1
NO308644B1 NO943049A NO943049A NO308644B1 NO 308644 B1 NO308644 B1 NO 308644B1 NO 943049 A NO943049 A NO 943049A NO 943049 A NO943049 A NO 943049A NO 308644 B1 NO308644 B1 NO 308644B1
Authority
NO
Norway
Prior art keywords
pct
aminopyridine
preparation
pharmaceutical composition
sec
Prior art date
Application number
NO943049A
Other languages
English (en)
Other versions
NO943049D0 (no
NO943049L (no
Inventor
Robert R Hansebout
Andrew R Blight
Original Assignee
Canadian Spinal Res Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Spinal Res Org filed Critical Canadian Spinal Res Org
Publication of NO943049D0 publication Critical patent/NO943049D0/no
Publication of NO943049L publication Critical patent/NO943049L/no
Publication of NO308644B1 publication Critical patent/NO308644B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO943049A 1992-12-18 1994-08-17 Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat NO308644B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002085785A CA2085785C (en) 1992-12-18 1992-12-18 The use of 4-aminopyridine in the treatment of a neurological condition
PCT/CA1993/000554 WO1994014439A1 (en) 1992-12-18 1993-12-20 The use of 4-aminopyridine in the treatment of a neurological condition

Publications (3)

Publication Number Publication Date
NO943049D0 NO943049D0 (no) 1994-08-17
NO943049L NO943049L (no) 1994-10-17
NO308644B1 true NO308644B1 (no) 2000-10-09

Family

ID=4150879

Family Applications (2)

Application Number Title Priority Date Filing Date
NO943049A NO308644B1 (no) 1992-12-18 1994-08-17 Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat
NO2012003C NO2012003I2 (no) 1992-12-18 2012-01-30 4-aminopyridin

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2012003C NO2012003I2 (no) 1992-12-18 2012-01-30 4-aminopyridin

Country Status (19)

Country Link
US (1) US5545648A (no)
EP (1) EP0626848B1 (no)
JP (1) JP3474569B2 (no)
KR (1) KR100301415B1 (no)
AT (1) ATE241981T1 (no)
AU (1) AU676251B2 (no)
BG (1) BG62272B1 (no)
BR (1) BR9305909A (no)
CA (1) CA2085785C (no)
CZ (1) CZ284441B6 (no)
DE (1) DE69333014T2 (no)
ES (1) ES2199957T3 (no)
FI (1) FI943765A (no)
HU (1) HU219583B (no)
NO (2) NO308644B1 (no)
NZ (1) NZ258844A (no)
RU (1) RU2160590C2 (no)
SK (1) SK280922B6 (no)
WO (1) WO1994014439A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792743A (en) * 1995-04-19 1998-08-11 Acorda Therapeutics Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
JPH09315972A (ja) * 1996-03-22 1997-12-09 Chugai Pharmaceut Co Ltd 脊髄損傷治療剤
US6190370B1 (en) 1997-07-25 2001-02-20 Arrow International, Inc. Devices, systems and methods for determining proper placement of epidural catheters
US7582680B1 (en) 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
US6503931B1 (en) * 1999-02-09 2003-01-07 The Uab Research Foundation Use of 4-amino pyridine for treatment of peripheral neuropathies
NO324322B1 (no) 2001-02-26 2007-09-24 Dynea Oy Anvendelse av herder samt fremgangsmate ved liming
NZ543953A (en) 2001-04-24 2007-04-27 Univ Chicago Method and compositions for treating mammalian nerve tissue injuries
US20040047843A1 (en) * 2002-02-12 2004-03-11 Uab Research Foundation Method for spinal cord reconnection
US7244748B2 (en) * 2002-12-06 2007-07-17 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
JP4533590B2 (ja) * 2003-02-28 2010-09-01 ファイザー株式会社 脊髄損傷患者における疼痛又は痙性軽減用医薬組成物
US20050192321A1 (en) * 2003-09-15 2005-09-01 Meythaler Jay M. Treatment of neuropathy with rapid release aminopyridine
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
AU2012211101B2 (en) * 2011-01-28 2017-04-20 Acorda Therapeutics, Inc. Use of potassium channel blockers to treat cerebral palsy
US8924325B1 (en) * 2011-02-08 2014-12-30 Lockheed Martin Corporation Computerized target hostility determination and countermeasure
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508715A (en) * 1981-07-01 1985-04-02 University Of Georgia Research Foundation, Inc. Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
EP0408650A1 (en) * 1988-04-08 1991-01-23 Massachusetts Institute Of Technology Method and composition for treating neurological disorders
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases

Also Published As

Publication number Publication date
HUT68171A (en) 1995-05-29
SK96994A3 (en) 1995-04-12
FI943765A (fi) 1994-10-14
NZ258844A (en) 1997-04-24
WO1994014439A1 (en) 1994-07-07
RU2160590C2 (ru) 2000-12-20
DE69333014T2 (de) 2004-05-06
HU219583B (hu) 2001-05-28
JP3474569B2 (ja) 2003-12-08
NO943049D0 (no) 1994-08-17
BG62272B1 (bg) 1999-07-30
NO2012003I2 (no) 2013-02-18
CZ225494A3 (en) 1995-03-15
KR950700062A (ko) 1995-01-16
FI943765A0 (fi) 1994-08-16
EP0626848B1 (en) 2003-06-04
HU9402647D0 (en) 1994-11-28
BG99047A (bg) 1995-06-30
NO2012003I1 (no) 2012-02-13
CZ284441B6 (cs) 1998-11-11
ATE241981T1 (de) 2003-06-15
CA2085785C (en) 2005-03-15
AU5691194A (en) 1994-07-19
CA2085785A1 (en) 1994-06-19
BR9305909A (pt) 1997-10-21
NO943049L (no) 1994-10-17
SK280922B6 (sk) 2000-09-12
JPH08504772A (ja) 1996-05-21
DE69333014D1 (de) 2003-07-10
US5545648A (en) 1996-08-13
AU676251B2 (en) 1997-03-06
EP0626848A1 (en) 1994-12-07
ES2199957T3 (es) 2004-03-01
RU94041207A (ru) 1996-06-20
KR100301415B1 (ko) 2001-11-22

Similar Documents

Publication Publication Date Title
NO2012003I2 (no) 4-aminopyridin
CZ176495A3 (en) The use of riluzol for preparing a medicament suitable for treating parkinson's disease and parkinson's syndromes
NO960067D0 (no) Nytt farmasöytisk preparat
ZA938421B (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders
PT914110E (pt) Metodo de modulacao da micro-circulacao
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
TW261532B (no)
NZ268110A (en) Use of ropivacaine salt in pharmaceutical compositions for the treatment of pain with sensoric block and minimal motor blockage
Domsky et al. Patient-controlled spinal analgesia for postoperative pain control
EE03385B1 (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
CZ176395A3 (en) The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation
IL103499A0 (en) Pharmaceutical compositions for treating anxiety in benzodiazepine withdrawn patients
AU673225B2 (en) Triazoloquinazolines for the treatment of diseases of the central vervous system
UA29005A (uk) Спосіб лікування трофічних виразок нижніх кінцівок

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: FAMPYRA-FAMPRIDIN; NAT. REG. NO/DATE: EU/1/11/699/001-002 20110823; FIRST REG. NO/DATE: EU , EU/1/11/699/001-002 20110720

Spc suppl protection certif: 2012003

Filing date: 20120130

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: FAMPYRA-FAMPRIDIN; NAT. REG. NO/DATE: EU/1/11/699/001-002 20110823; FIRST REG. NO/DATE: EU , EU/1/11/699/001-002 20110720

Spc suppl protection certif: 2012003

Filing date: 20120130

Extension date: 20181220

MK1K Patent expired
SPCX Expiry of an spc

Free format text: PRODUCT NAME: FAMPYRA-FAMPRIDIN; NAT. REG. NO/DATE: EU/1/11/699/001-002 20110823; FIRST REG. NO/DATE: EU , EU/1/11/699/001-002 20110720

Spc suppl protection certif: 2012003

Effective date: 20190107